ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$0.52 USD
-0.05 (-8.70%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.52 0.00 (0.37%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
ALX Oncology Holdings Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ALXO 0.52 -0.05(-8.70%)
Will ALXO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALXO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALXO
ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services
ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for ALXO
Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor
ALX Oncology Confirms Directors at Annual Meeting
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO)
ALX Oncology Holdings (ALXO) Gets a Buy from Piper Sandler